U.S. Physical Therapy, Inc.
USPH
$80.27
-$1.74-2.12%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.31% | 12.12% | 8.90% | 7.64% | 7.53% |
| Total Other Revenue | 26.67% | 26.38% | 22.77% | 17.99% | 10.87% |
| Total Revenue | 16.25% | 14.31% | 10.99% | 9.20% | 8.04% |
| Cost of Revenue | 16.40% | 14.09% | 10.37% | 5.02% | 4.21% |
| Gross Profit | 15.76% | 15.04% | 13.11% | 25.59% | 22.93% |
| SG&A Expenses | 17.31% | 15.85% | 12.20% | 13.29% | 8.96% |
| Depreciation & Amortization | 25.88% | 46.95% | 74.04% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.89% | 15.41% | 12.35% | 10.30% | 9.24% |
| Operating Income | 11.04% | 5.45% | 0.69% | 0.91% | -0.92% |
| Income Before Tax | 55.47% | 26.23% | 21.94% | -21.99% | -15.99% |
| Income Tax Expenses | 53.69% | 24.37% | 20.18% | -14.95% | -3.86% |
| Earnings from Continuing Operations | 56.05% | 26.84% | 22.51% | -24.00% | -19.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -73.89% | -66.07% | -57.84% | 23.08% | 26.50% |
| Net Income | 49.89% | 15.25% | 11.28% | -24.36% | -16.50% |
| EBIT | 11.04% | 5.45% | 0.69% | 0.91% | -0.92% |
| EBITDA | 15.17% | 9.76% | 4.06% | 2.81% | 1.21% |
| EPS Basic | 116.55% | 76.87% | 37.38% | -45.36% | -45.27% |
| Normalized Basic EPS | -20.35% | -22.07% | -20.72% | 18.96% | 17.17% |
| EPS Diluted | 116.55% | 76.87% | 37.38% | -45.25% | -45.17% |
| Normalized Diluted EPS | -20.35% | -22.07% | -20.72% | 18.96% | 17.17% |
| Average Basic Shares Outstanding | 0.72% | 2.83% | 6.23% | 9.90% | 13.87% |
| Average Diluted Shares Outstanding | 0.72% | 2.83% | 6.23% | 9.90% | 13.87% |
| Dividend Per Share | 2.30% | 2.31% | 2.33% | 2.94% | 3.57% |
| Payout Ratio | -0.31% | -0.05% | -0.01% | 0.51% | 0.43% |